Malaria vaccine

According to a report, following decades of research there is a new vaccine for malaria. Reportedly, rts,1 which was produced by GlaxoSmithKline and path a non profit organisation is being given to children in west Africa. According to the report, children in Burkina Faso will be next to receive it. Reportedly, a second vaccine, r21 has been approved by the world health organisation.

According to reports, nearly all of the 200 million cases of malaria occur in Africa, comprising 94% of cases and 95% of deaths globally. Reportedly, nearly half a million children die of malaria every year. According to a report, the vaccine is given in a series of four doses from around five months of age.